Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
DIAGNOSIS AND MANAGEMENT OF THE PATIENT WITH TREMOR KELVIN Tremor, the most common form of abnormal involuntary movement (AIM), is a rhythmic oscillation of a body region produced by alternating contractions of reciprocally innervated muscles.I,llt occurs across a wide spectrum of neurological disorders and is easily distinguished from other AIMs such as chorea, tics, and myoclonus by its rhythmic, repetitive and stereotypical appearance. Tremor causes not only discomfort and social embarrassment for patients, but also disability. Since successful treatment depends on the correct diagnosis, it is important for the clinician to recognize the various presentations of tremor and associated symptoms. This article describes the general clinical approach to the patient who presents with tremor and reviews the most common tremor syndromes and their management. CLASSIFICATION TREMOR OF When evaluating a patient who presents with tremor, first categorize the tremor based on its positional properties. Tremor can be divided into two main types: rest and action. Rest tremor occurs in a body part that is relaxed or supported against gravity and not involved in purposeful activities, for example, a hand tremor evident when the upper limb rests on the arm of a chair. When intermittent or minimal, a rest tremor can be brought out or enhanced on examination by having the patient concentrate on other tasks, such as performing arithmetic or opening and closing the contralateral hand. The presence of a rest tremor is virtually synonymous with parkinsonism, a condition with multiple etiologies, including drug-induced (due mainly to neuroleptics) and other neurodegenerative disorders such as multiple system atrophy (MSA) or progressive supranuclear palsy (PSP). Parkinson's disease (PD), however" is by far the most common cause of par- L. CHOU, MD kinsonism, comprising approximately three quarters of all cases seen in movement disorders centers.3 Action tremor is present during the voluntary contraction of muscles, and can be subdivided into four types: postural, kinetic, isometric, and task-specific. Postural tremor is seen during the maintenance of an anti-gravity posture, such as when a patient holds a newspaper up to read, whereas kinetic tremor happens during voluntary movement. Often brought out using the fingernose-finger test, a kinetic tremor can occur at the beginning of the movement, during the course of the movement, or when approaching a target. In the latter condition, it is also known as an intention tremor, commonly seen with cerebellar lesions. Isometric tremors are present during voluntary muscle contractions not accompanied by movement, for example, when standing or when making a fist. Task-specific tremors, as the name implies, occur only during specific activities, such as writing, singing, or playing an instrument. The postural and kinetic tremor subtypes are seen far more frequently than the isometric and task-specific subtypes. Just as each tremor type has multiple etiologies, more than one tremor type can occur in the same condition. For example, PO patients often have an action component in addition to their classic rest tremor, while the postural tremor seen in essential tremor (ET) can sometimes persist when the hands rest in the patient's lap. Though this overlap can sometimes cause difficulty for the diagnosing clinician, a tremor that diminishes with voluntaty movement is likely to be a rest tremor, while a tremor that is present at rest but worsens with movement is probably an action tremor. CLUES TO THE OF TREMOR DIAGNOSIS Once the predominant type of tremor is identified, a short differential diagnosis can be generated (Table 1) and narrowed down based on clues obtained from the clinical history and neurological examination. Historical elements that are important to elicit include: 1) age at onset of the tremor, 2) mode of onset (sudden vs. gradual), 3) anatomical site(s) affected by the tremor, 4) rate of progression to other sites, 5) exacerbating and remitting factors (such as alcohol responsiveness), 6) histoty of alcohol abuse, and 7) family history of tremor. Furthermore, many pharmacologic agents can cause tremor (Table 2), so a thorough review of the patient's medications is essential. Associated examination findings that may shed light on the underlying etiology of the tremor include bradykinesia or rigidity (PO); nystagmus, scanning speech, ataxia (cerebellar lesion); and a wide variation in tremor frequency (psychogenic). If the diagnosis can be established on clinical criteria and the patient responds to treatment, ancillaty studies are usually unnecessary. However, in young patients «50 years of age) with tremor, Wilson's disease (WD) should always be excluded, because it is devastating and potentially life-threatening if left untreated. WD is a rare, autosomal recessive disorder believed to be caused by mutations in a gene encoding a copper transporting ATP-ase, resulting in abnormal deposition of copper in brain, liver and other organs of the body. Although classically described as "wing-beating", the tremor in WO can occur in any pattern and is the most common neurological manifestation of the disease.4 Most cases can be ruled out with a normal serum ceruloplasmin and 24-hour urinary copper excretion. Other groups of patients in whom investigational studies may be helpful include those with asymmetrical, cerebellar, or postural tremors. Asymmetrical or cerebellar tremors may result from focal lesions such as neoplasm, stroke, hemorrhage or demyelinating disease and may be de- 135 VOL. 87 No.5 MAY 2004 tected with a magnetic resonance imaging stUdy of the brain. Patients who present with postural tremor may have hyperthyroidism as an underlying etiology and should have their thyroid function checked. hol, but these features are not present in every patient. Although ET can occur at any age, its prevalence generally increases with age. ET tends to start distally in the arms with a typical flexion-extension motion at the wrists or abduction-ad- COMMON TREMOR SYNDROMES AND THEIR MANAGEMENT duction movement of the fingers. Although it may be unilateral in onset, both sides will eventually be involved. The most common anatomical sites of involvement after the hands are (in decreasing order) the head, voice, legs, and chin.6 The tremor tends to in- The most common tremor syndromes encountered in clinical practice are ET and PD. Although cerebellar and psychogenic tremors are less frequently seen, they are important for the general clinician to be aware of and will be briefly reviewed. Iatrogenic causes of tremor are common, and may even mimic ET or PD. If a patient is taking a medication known to induce tremor (Table 2), that medication should be discontinued before initiating other therapy. ESSENTIAL TREMOR (ET) ET is the most common move- ment disorder.2 The diagnosiscan be made when a persistent, bilateral, mainly symmetrical, postural and/or kinetic tremor of the hands or arms is present, without other neurological signs or exposure to drugs that may cause tremor.5 A head tremor can also be part of the syndrome, either in addition to the hand tremor or in isolation, as long as there is no dystonic postUring. Clinical or historical features consistent with a diagnosis ofET include a positive family history and improvement of the tremor with alco- crease with stress, anxiety, excitement, emotional upset, fatigue or cold temperature. Although ET is sometimes preceded by the term "benign", many patients dispute the adjective. ET causes both physical and social disability. Simple tasks such as signing a check, eating, drinking from a cup, shaving, brushing teeth, and dressing can become frustrating ordeals, and embarrassed patients often avoid social sitUations. Primidone (Mysoline) and propranolol (Inderal) continue to be the mainstays of treatment for ET. Primidone, an anticonvulsant, may be the more effective agent, with approximately 70% of patients experiencing benefit, compared to 50% of patients on propranoloU Though dosages between 50 and 250 mg of primidone daily are usually needed to reduce tremor,8 this medication should be started at a low dose and titrated slowly up in order to minimize adverse effects. Primidone is usually prescribed in one Table 1. Common Tremor Types, Characteristics, single daily dose at bedtime, beginning with 25 mg, and increased by 25 mg weekly until the desired tremorlytic effect is obtained or side effects occur. Drowsiness is the most common side effect, but patients may also experience nausea, vertigo and unsteadiness. Propranolol, a beta-blocker, is usually effective between 240 and 320 mg daily.9 Patients are frequently referred to movement disorders centers and labeled as having "failed" propranolol treatment, when in fact, an adequate dose was never administered. As with primidone, propranolol should be started at low doses and increased over weeks, while monitoring blood pressure and pulse. Contraindications for the use of propranolol include cardiac conduction block, heart failure, asthma and diabetes; side effects include lightheadedness, fatigue, nausea and depression. Other medications for ET are generally not proven to be as effective as primidone or propranolol, though topiramate was recently shown to reduce tremor in a double-blind, placebo-con trolled trial. 10 Benzodiazepines such as alprazolam or clonazepam may also help if the patient has concurrent anxiety. When the medications fail to control the tremor, surgery should be considered. Stereotactic ablation of the ventral intermediate nucleus (Vim) of the thalamus used to be the preferred surgical procedure for control of ET tremor, but has become obsolete with the advent of deep brain stimulation and Examples Type of Tremor Clinical Characteristics Common Examples Rest Occurs when body part is supported against gravity and not engaged in activity Parkinson's disease, drug-induced parkinsonism, multiple system atrophy, progressive supranuclear palsy Postural Occurs when body part is maintained against gravity Physiologic, essential tremor, druginduced, alcohol withdrawal, post- Kinetic Occurs during voluntary movement Intention Occurs toward the end of a goal-directed movement Action 136 MEDICINE AND HEAL TH / RHODE ISLAND traumatic, psychogenic Physiologic, essential tremor, druginduced, post-traumatic, psychogenic, cerebellar lesions Cerebellar lesions (DBS) of the thalamus.]] Thalamic DES involves the placement of an electrode in the Vim nucleus. This electrode is connected to a wire, which is tunneled under the skin and attached to an implantable pulse generator located in the subcutaneous tissue overlying the pectoralis muscle. This pulse generator can then be switched on or off and programmed using a portable computer. The clinical effect of DES is identical to that of ablation, but DBS holds an advantage over ablation in that turning the stimulator off can reverse its effects. Thalamic stimulation can also be performed bilaterally with fewer side effects than thalamotomy. PARKINSON'S DISEASE (PD) PD is a slowly progressive neurodegenerative disorder characterized clinically by the classic triad of rest tremor, bradykinesia and rigidity. Although a fourth feature, postural instability, is sometimes included among the cardinal manifestations, this symptom is often absent until the later stages of disease. The diagnosis ofPD is made clinically, based on the presence of two out of the three cardinal features and an unequivocal, sustained response to dopaminergic therapy.3 PD is uncommon under the age of 40 and increases rapidly in incidence above the age of 60 for both males and females, with a mean age at diagnosis of70.5 yearsY Approximately 70% of PD patients will have tremor as the initial symptom.!3 The rest tremor in PD has a frequency of 4-6 Hz and a characteristic "pill-rolling" action when the arm and hands are involved. As mentioned earlier, it is not unusual to see an action or postural tremor with PD, especially in the later stages of disease, although this action component generally has a higher frequency (~7 to 12 Hz). In addition to the arms, PD tremor can also affect the legs, lips, jaw, chin, and tongue, but rarely involves the head, differentiating it from ET. The tremor tends to start intermittently in one arm, but gradually becomes more constant, and generally progresses to the contralateral side a few years into the course of the disease. Similar to ET, factors that exacerbate tremor in PD include anxiety, stress, or emotional states or extremes in temperature. The treatment of PD remains symptomatic. Although research efforts are focusing on neuroprotective strategies and treatment, there are no therapies that unequivocally slow the progression of PD. Therefore, if the patient's symptoms are not limiting, treatment does not need to be initiated. Nevertheless, most patients with prominent rest tremor will opt for treatment because the tremor is annoying or embarrassing. Unfortunately, the response of parkinsonian tremor to pharmacologic treatment is highly variable.! Table 2. Drugs that commonly cause tremor Alcohol (chronic use or withdrawal) Anti-arrhythmic drugs Amiodarone Procainamide Antiepileptic agents Carbamazepine Valproic acid Benzodiazepine withdrawal Cyclosporine Lithium Neuroleptics Stimulants Albuterol Amphetamines Caffeine Cocaine Theophylline As a general rule, if the pa- tient is young «70 years of age) and has other features of PD such as bradykinesia or rigidity in addition to tremor, most PD experts would recommend initiating treatment with a dopamine agonist such as pramipexole (Mirapex) or ropinirole (Requip).!4 Although carbidopa/levodopa (Sinemet) is clearly the most effective anti-parkinsonian drug overall, it is associated with long term motor complications such as fluctuations and dyskinesias, which can be delayed by initiating therapy with a dopamine agonist.!5,!6 The dopamine agonists are administered three times a day; common side effects include nausea, dizziness, confusion and excessive sleepiness. In order to minimize these adverse effects, the agonists should be started at a low dose and increased tion independently. The anticholinergic trihexyphenidyl hydrochloride (Artane) can improve tremor in PD, but is ineffective in controlling the other cardinal motor features of PD. Therefore, its use is limited to the PD patient who presents with a predominant tremor, but minimal bradykinesiaand rigidity,or as adjunctive therapy for a tremor that is resistant to the dopaminergic medications mentioned earlier. Sedation is the main side effect When the patient presents with PD symptoms at a more advanced age (>70 years of age), carbidopa/levodopa is a more appropriate choice. Carbidopa/ levodopa comes in both standard and controlled release formulations, but patients tend to respond less predictably to the controlled release formulation. It in addition to anticholinergic symptoms such as blurred vision, dry mouth and urinary retention, and is usually the limiting factor in the use of this agent. Trihexyphenidyl should alsobe used cautiously in elderly patients because they are more prone to developing cognitive difficulties. Dosages needed to suppress tremor can range from 2 to 12 mg daily (maximum dosage 32 mg); again, it is wise to start at a low dose and titrate up for effect. If trihexyphenidyl is ineffective or poorly tolerated, propranolol (Inderal) or amantadine hydrochloride (Symmetrel) can be tried. If the tremor is refractory to pharmacologic modalities, DES should be considered. The three anatomical sites in which stimulation has been studied is reasonable to begin with the 25/100 mg dose of carbidopa/levodopa two to three times a day, and then increase the dosage as needed for the patient to func- for PD include the thalamus, globus pallidus interna (GPi) and the subthalamic nucleus (STN). Thalamic stimulation is effective only for tremor, weekly until a therapeutic reached. dose is 137 VOL. 87 NO.5 MAY 2004 and therefore is helpful for only a small proportion of PO patients. Both GPi and STN stimulation have been shown to improve all cardinal features of PO, -including tremor,17 and either would be an appropriate option for the majority of patients. CEREBELLAR TREMOR Cerebellar tremor most often presents as a kinetic tremor with a prominent intention component.5 The ipsilateral arm or leg is usually affected when a cerebellar hemisphere in involved. Lesions of the cerebellar vermis, or midline, often cause an isolated postural tremor of the trunk and head, commonly referred to as "titubation". Multiple sclerosis (MS) is the most common cause; other causes include tumors, ischemic or hemorrhagic strokes, alcoholic cerebellar degeneration, vitamin E deficiency, or paraneoplastic syndromes. Treatment of the underlying cause (i.e. immunomodulatory therapy in MS, resection of a tumor) can sometimes resolve the tremor. For persistent cerebellar tremor, however, no medication has been proven to be helpful. A sensible approach is first to try the agents that are helpful for ET. If these fail to relieve the tremor, isoniazid or DBS can be considered. Isoniazid resulted in mild improvement in one small randomized crossover trial of six patients with severe postural cerebellar tremor, 18 while thalamic DBS showed some benefit for cerebellar tremor in a small number of patients with MS.19 PSYCHOGENIC TREMOR Although there are no precise estimates of the incidence and prevalence of psychogenic tremors, clinical experience suggests that it is not rare. While it can be difficult to differentiate between psychogenic and organic tremors, the characteristic that all psychogenic tremors have in common is variability in the tremor amplitude and frequency.2 Because of this variability, the tremor often cannot be easily classified. Psychogenic tremors frequently increase in severity with attention, and decrease when the patient is forced to concentrate on other tasks. 138 MEDICINE AND HEALTH I RHODE ISLAND Other criteria useful in the diagnosis of this tremor include sudden or abrupt onset, variable course with spontaneous remissions, ability to perform some functions despite severe tremors, and unresponsiveness to anti-tremor medications.2O Often, "false" signs will appear on the neurologic examination, such as give-way weakness or bizarre sensory findings. Psychotherapy is the main treatment approach. SUMMARY Tremor is a common and disabling symptom that is associated with a large number of neurological disorders, including ET and PD. The positional properties of the tremor allow the clinician to generate a short list of diagnostic possibilities, which can then be narrowed down based on the clinical history and the neurological examination. A number of medical and surgical therapies are availablefor tremor, but a successful response to treatment depends on an accurate diagnosis. REFERENCES 1. Wasielewski PG, Burns JM and Koller We. Mov Disord 1998; 13 SuppI3:90100. 2. Zesiewicz TA and Hauser RA. Neurol Clin 2001; 19:651-680. 3. Colcher A and Simuni T. Med Clin NorthAm 1999; 83:327-347. 4. Pfeiffer RF. Wilson's Disease. In Watts RL and Koller WC, ed. Movement Disorders: Neurologic Principles and Practice. New York: McGraw-Hill. 1997:623-638. 5. Deuschl G, Bain P and Brin M. Mov Disord 1998; 13 SuppI3:2-23. 6. Koller WC, Busenbark K and Miner K. Ann Neuro11994; 35:717-723. 7. Koller WC, Busenbark K, Gray C, et al. Clin NeuropharmacoI1992; 15:81-87. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. Koller WC and Royse VL. Neurol 1986; 36:121-124. KollerWe. ArchNeurol 1986; 43:42-43. Connor GS. Neuro12002; 59:132-134. Benabid AL, Pollak P, Gao D, et al.] Neurosurg 1996; 84:203-214. Van Den Eeden SK, Tanner CM, Bernstein AL, et al. Am ] Epidemiol 2003; 157:1015-1022. Hoehn MM and Yahr MD. Neurol 1967; 17:427-442. Olanow CW, Watts RL and Koller We. Neuro12001; 56:S1-S88. Rascol 0, Brooks DJ, KorczynAD, et al. NE]M2000; 342:1484-1491. Parkinson Study Group. ]AMA 2000; 284:1931-1938. Deep Brain Stimulation for Parkinson's Disease Study Group. NE]M 2001; 345:956-963. 18. Hallett M, Lindsey JW, Adelstein BD, et al. Neuro11985; 35:1374-1377. 19. Montgomery EB,Jr., Baker KB, Kinkel RP, et al. Neuro11999; 53:625-628. 20. Koller W, Lang A, Vetere-Overfield B, et al. Neuro11989; 39:1094-1099. Kelvin L. Chou,MD, is a Movement DisordersFellow at the Parkinson's Disease and Movement Disorders Center, Pennsylvania Hospital, University of Pennsylvania School of Medicine, and will bejoining the Department ofClinical Neurosciences at Brown Medical School as an Assistant Professorof Neurology in July. CORRESPONDENCE: Kelvin L. Chou, MD Parkinson's Disease and Movement Disorders Center 330 South Ninth Street Philadelphia, PA 19107 Phone: (215) 829-8593 Fax: (215) 829-7552 e-mail: [email protected]